Clinical significance of STC1 gene expression in patients with colorectal cancer

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 325-329

  Tamura, Shuzo ^a   Oshima, Takashi ^b   Yoshihara, Kazue ^b   Kanazawa, Amane ^a   Yamada, Takanobu ^a   Inagaki, Daisuke ^a   Sato, Tsutomu ^b   Yamamoto, Naoto ^a   Shiozawa, Manabu ^a   Morinaga, Soichiro ^a   Akaike, Makoto ^a   Kunisaki, Chikara ^b   Tanaka, Katsuaki ^b   Masuda, Munetaka ^c   Imada, Toshio ^c  

^a Kanagawa Cancer Center   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; PCR; Prognostic factor; Stanniocalcin 1

Indexed keywords

MESSENGER RNA;

AGED; ARTICLE; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANNIOCALCIN 1 GENE;

AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 79851486436     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ishibashi K and Imai M: Prospect of stanniocalcin endocrine/paracrine system in mammals. Am J Physiol Renal Physiol 282: F367-F375, 2002. (Pubitemid 34654525)
2. Chang AC, Jellineck DA and Reddel RR: Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10: 359-373, 2003.
3. Chang AC, Janosi J, Hulsbeek M, de Jong D, Jeffrey KJ, Noble JR and Reddel RR: A novel human cDNA highly homologous to the fish hormone stanniocalcin (STC). Mol Cell Endocrinol 112: 241-247, 1995.
4. Olsen HS, Cepeda MA, Zhang QQ, Rosen CA and Vozzolo BL: Human stanniocalcin: a possible hormonal regulator of mineral metabolism. Proc Natl Acad Sci USA 93: 1792-1796, 1996. (Pubitemid 26082959)
5. Chang AC, Jeffrey KJ, Tokutake Y, Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y and Reddel RR: Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats. Genomics 47: 393-398, 1998. (Pubitemid 28110652)
6. Varghese R, Wong CK, Deol H, Wagner GF and DiMattia GE: Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139: 4714-4725, 1998. (Pubitemid 28487791)
7. Madsen KL, Tavernini MM, Yachimec C, Mendrick DL, Alfonso PJ, Buergin M, Olsen HS, Antonaccio MJ, Thomson AB and Fedorak RN: Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol 274: G96-G102, 1998.
8. Wagner GF, Vozzolo BL, Jaworski E, Haddad M, Kline RL, Olsen HS, Rosen CA, Davidson MB and Renfro JL: Human stanniocalcin inhibits renal phosphate excretion in the rat. J Bone Miner Res 12: 165-171, 1997. (Pubitemid 27086296)
9. Lu M, Wagner GF and Renfro JL: Stanniocalcin stimulates phosphate reabsorption by flounder renal proximal tubule in primary culture. Am J Physiol 267: R1356-R1362, 1994.
10. Deol HK, Varghese R, Wagner GF and Dimattia GE: Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Endocrinology 141: 3412-3421, 2000. (Pubitemid 32269031)
11. Kahn J, Mehraban F, Ingle G, Xin X, Bryant JE, Vehar G, Schoenfeld J, Grimaldi CJ, Peale F, Draksharapu A, Lewin DA and Gerritsen ME: Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol 156: 1887-1900, 2000.
12. Gerritsen ME, Soriano R, Yang S, Ingle G, Zlot C, Toy K, Winer J, Draksharapu A, Peale F, Wu TD and Williams PM: In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol Genomics 10: 13-20, 2002.
13. Wary KK, Thakker GD, Humtsoe JO and Yang J: Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2: 25, 2003.
14. Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV Jr. and Gerritsen ME: Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor. J Biol Chem 278: 47654-47659, 2003. (Pubitemid 37523210)
15. Jiang WQ, Chang AC, Satoh M, Furuichi Y, Tam PP and Reddel RR: The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development. J Endocrinol 165: 457-466, 2000. (Pubitemid 30341094)
16. Stasko SE and Wagner GF: Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse. J Endocrinol 171: 237-248, 2001. (Pubitemid 33061700)
17. Stasko SE and Wagner GF: Stanniocalcin gene expression during mouse urogenital development: a possible role in mesenchymal-epithelial signalling. Dev Dyn 220: 49-59, 2001. (Pubitemid 32049458)
18. Yoshiko Y, Aubin JE and Maeda N: Stanniocalcin 1 (STC1) protein and mRNA are developmentally regulated during embryonic mouse osteogenesis: the potential of stc1 as an autocrine/paracrine factor for osteoblast development and bone formation. J Histochem Cytochem 50: 483-492, 2002.
19. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS and Andersson LC: Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci USA 97: 3637-3642, 2000.
20. Sheikh-Hamad D, Rouse D and Yang Y: Regulation of stanniocalcin in MDCK cells by hypertonicity and extracellular calcium. Am J Physiol Renal Physiol 275: F417-F424, 2000. (Pubitemid 30163241)
21. Nguyen A, Chang AC and Reddel RR: Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogen 28: 1982-1992, 2009.
22. Wu S, Yoshilo Y and De Luca F: Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis. J Biol Chem 281: 5120-5127, 2006. (Pubitemid 43847777)
23. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, Dimattia G, Sullivan DE and Prockop DJ: Multipotent stromal cells (MSCs) are activated to reduce apoptosis in part by up-regulation and secretion of stanniocalcin-1 (STC-1). Stem Cells 27: 670-681, 2009.
24. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y and Nakamura Y: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61: 2129-2137, 2001.
25. Fujiwara Y, Sugita Y, Nakamori S, Miyamoto A, Shiozaki K, Nagano H, Sakon M and Monden M: Assessment of stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. Int J Oncol 16: 799-804, 2000.
26. Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS and Rooker S: Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer 8: 187, 2008.
27. Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H, Ishiguro N and Takahashi M: Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. Am J Pathol 161: 249-256, 2002. (Pubitemid 34760790)
28. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, Bast RC, Lin SH and Liu J: Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 102: 812-827, 2010.
29. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE and Venter DJ: Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62: 1289-1295, 2002. (Pubitemid 34407780)
30. McCudden CR, Majewski A, Chakrabarti S and Wagner GF: Colocalization of stanniocalcin-1 ligand and receptor in human breast carcinomas. Mol Cell Endocrinol 213: 167-172, 2004. (Pubitemid 38210048)
31. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA and King MC: BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 99: 7560-7565, 2002. (Pubitemid 34568730)
32. Wascher RA, Huynh KT, Giuliano AE, Hansen NM, Singer FR, Elashoff D and Hoon DS: Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. Clin Cancer Res 9: 1427-1435, 2003. (Pubitemid 36418397)
33. Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K and Kristiansen G: Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Eur Urol 55: 669-678, 2009.
34. Ieta K, Tanaka F, Yokobori T, Kita Y, Haraguchi N, Mimori K, Kato H, Asao T, Inoue H, Kuwano H and Mori M: Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. Int J Cancer 125: 926-931, 2009.